| Date | Event | Description |
|---|---|---|
| 27 February 2020 | Amended | Clarification statement added from Alan Smyth, Co‐ordinating Editor on 27 February 2020: This review was found by the Cochrane Funding Arbiters, post‐publication, to be noncompliant with the Cochrane conflict of interest policy, which includes the relevant parts of the Cochrane Commercial Sponsorship Policy. The review will be updated by August 2020; both authors of the future update will be free of conflicts. Current version (post‐publication): Colleen Oliver: no conflicts of interest. Helen Watson received funding for travel from Abbott Nutrition (manufacturer of ENSURE® ORIGINAL THERAPEUTIC NUTRITION with omega‐3 fatty acid ALA) (June 2013). |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.